特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 仪粉e r们，今天是高薪精品仪器职位专辑，有不少 新的雇主 哦！ 销售精英，热招职位 Ho t r e c r u itme n t p o siti o n s 安捷伦科技（中国）有限公司 耗材 渠道销售经理 上海- 1 8 k - 2 8 k · 1 3薪 岗位要求： 3~5年渠道管理经验，具有仪器耗材或相关领域背景优先；丰富的实验室行业销售经验者优先。 德国耶拿分析仪器有限公司 区域销售代表 南宁- 8 k - 1 5 k · 1 3薪 岗位要求： 本科及以上学历，化学、环境科学、仪器仪表等相关专业优先；3年以上化学分析仪器、实验室设备或工业检测领域销售经验，具 备成熟客户资源者优先。 岗位要求： 大专及以上学历，具有化学、生物、医药、食品、环境、等相关专业背景优先；热爱销售工作，有责任心。 骇思仪器科技(上海)有限公司 销售工程师 北京- 7 k - 2 0 k · 1 2薪 岗位要求： 本科及以上学历，性别不限；生物、化学、环境、材料或仪器分析等相关专业教育背景；3年及以上科 ...

Core Viewpoint - Fudan University has announced procurement intentions for 24 items of laboratory equipment, with a total budget of 110 million yuan, scheduled for procurement between January and July 2025 [1][2]. Procurement Overview - The procurement includes high-resolution long-term fluorescence microscopes, ultra-high vacuum sample preparation systems, ultra-high vacuum low-temperature strong magnetic field scanning tunneling microscopes, and systems for the growth and preparation of two-dimensional materials in ultra-high vacuum [2][3]. - The total budget for the procurement is 110 million yuan, with specific items and their respective budgets detailed in the document [2][3]. Specific Equipment and Budget - High-resolution long-term fluorescence microscope: 202 million yuan, required for integrated imaging systems with advanced optical paths and environmental interference elimination [3]. - Gas phase liquid nitrogen tanks: 195 million yuan, for long-term preservation of biological samples at temperatures below -180°C [3]. - Ultra-high vacuum low-temperature strong magnetic field scanning tunneling microscope: 400 million yuan, for atomic-scale characterization of two-dimensional materials [3]. - Network analyzer: 840 million yuan, aimed at high-frequency and ultra-high-frequency testing for photonic and terahertz devices [5]. Additional Equipment - Multi-dimensional energy metabolism measuring instrument: 140 million yuan, designed for high precision and stability in measuring energy metabolism in various cell types [5]. - Dual-energy X-ray bone densitometer: 125 million yuan, for clinical screening and analysis of bone density and composition [5]. - ATE testing machine: 1000 million yuan, for advanced chip testing and verification [6]. Procurement Timeline - The expected procurement period is set for January to July 2025, with specific timelines for each item outlined in the procurement intentions [2][4].

Core Viewpoint - The establishment of the copper-based new materials key laboratory in Shanxi Province marks a significant recognition of innovation capabilities in the field, focusing on technological innovation, achievement transformation, and talent cultivation to support the transformation and upgrading of the copper industry [1][2]. Group 1: Laboratory Establishment and Recognition - The copper-based new materials laboratory, led by Northern Copper Industry, passed the evaluation organized by the Shanxi Provincial Science and Technology Department, indicating its authoritative recognition in innovation capabilities and platform construction [2]. - The laboratory was approved for construction in December 2022 and has made significant progress in key technology breakthroughs, research platform construction, and achievement transformation over the past two years [2][3]. Group 2: Innovation and Research Collaboration - The laboratory focuses on building a full-chain innovation system aligned with Shanxi Province's "14th Five-Year" new materials industry plan, integrating basic research, technology tackling, and achievement transformation [3]. - Northern Copper Industry, in collaboration with universities, has applied for seven provincial and municipal research projects and signed two horizontal projects, promoting core technology iteration [3]. Group 3: Research Achievements and Talent Development - Over the past two years, the laboratory has published ten papers, applied for ten invention patents, and achieved significant breakthroughs in product development, including a record-breaking 20,000 meters length of 6μm ultra-thin copper foil [4]. - The laboratory has also trained over 20 master's and doctoral students and 18 technical backbones, creating a virtuous cycle of talent cultivation and research promotion [4]. Group 4: Future Goals and Strategic Direction - The laboratory aims to continue its mission in tackling key core technologies in the high-end copper-based new materials field, enhancing innovation outcomes, and fostering high-level academic exchanges [4]. - The leadership of the laboratory emphasizes resource coordination and strategic layout to overcome challenges such as equipment shortages and technological blockades, aiming to elevate the copper industry in Shanxi to a first-class innovation hub [4].

导读： 我国首个合成生物学院在天津大学揭牌，将聚焦科研突破与人才培养，推动合成生物学发展。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 近日， 天津大学合成生物与生物制造学院正式揭牌。据悉，这是我国"世界一流建设高校"中 首个合成生物学院 ，也是天津大学统筹推进教育科技人才体制机制一体改革的重要举措。 新成立的合成生物与生物制造学院将整合多学科资源，用人工智能赋能教学科研，搭建全方位 的人才培养与科研创新平台。 科研方面，学院力争实现前瞻性基础研究和引领性原创成果的重 大突破，在部分方向实现领跑；产出一批共性关键技术、前沿引领技术、颠覆性创新技术，为 我国医药健康、能源材料、生物育种和环境治理等提供科技支撑。人才培养方面，学院突破学 科限制，建立完善的专业动态调整机制，设立交叉学科课程及实践课题，为学生参与跨学科学 习和研究创造条件；还将探索"以任务带学科，以任务聚人才"的培养模式，通过重大任务和重 点项目，开展研究性项目式教学，所有学生都将参与科研项目训练，构建多学科贯通的知识体 系，形成多维能力；同时，将汇聚全球优质资源，为拔尖学 ...

导读： 片上光谱仪结合光谱分析与芯片技术，实现便携高效分析，应用广泛。光引科技获中科创星融资，专注提供先进片上光电芯片及光谱分析解决方案，推动 光谱技术大众化。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，中国医学科学院发布3项仪器设备采购意向，预算总额达2 . 2 1亿元，涉及全自动细胞形态学分析仪、自动化前处理加样系统、超高效液相 色谱仪、全自动细菌鉴定药敏分析仪、全自动生物质谱检测系统、自动血液微生物培养系统、全自动生化免疫流水线等，预计采购时间为2 0 2 5 年5~9月。 光谱仪作为分析化学、生物传感和材料表征等领域的重要工具，近年来在市场需求推动下朝着小型化、高性能和低成本方向快速发展。尤其是 在移动物联网技术的普及背景下，便携式光谱仪在医疗健康监测、化学检测和高光谱成像等原位、体外甚至体内应用中展现出巨大潜力。然 而， 小型化光谱仪面临着一个根本性的技术难题：如何在大幅缩减尺寸的同时，实现高分辨率、高准确度以及超大工作带宽这三个关键性能指 标的突破 。 传统观点认为，小型化会不可避免地导致性能折衷，使得微型光谱仪仅适 ...

Core Viewpoint - The article discusses the competitive landscape of the Chinese instrument industry as it approaches 2025, highlighting the impact of external factors such as U.S. tariffs and geopolitical risks, as well as domestic economic reforms on market dynamics [2][5]. Market Overview - The total market capitalization of 42 listed instrument companies in China reached 626.56 billion yuan, a decrease of 12.04 billion yuan compared to 2024, with an average market cap of approximately 149.18 billion yuan [4][5]. - Among these companies, 36 experienced market cap growth, with several companies seeing increases exceeding 50%, indicating a strong recovery trend in the industry [5][17]. Company Rankings - The top five companies by market capitalization are: 1. Mindray Medical: 275.92 billion yuan, down 23.98% [3][5] 2. Sunny Optical: 633.41 billion yuan, up 47.04% [3][5] 3. GD Infrared: 380.1 billion yuan, up 37.77% [3][5] 4. BGI Genomics: 295.93 billion yuan, up 39.12% [3][5] 5. Antu Biological: 220.06 billion yuan, down 26.70% [3][5] Sector Performance - The life sciences instrument sector has seen significant declines, with major players like Mindray Medical and Antu Biological experiencing substantial market cap reductions due to ongoing healthcare reforms and pricing pressures [16][14]. - In contrast, the optical instrument sector has shown strong performance, with companies like Sunny Optical and Yongxin Optical achieving notable market cap increases due to recovery in the smartphone and new energy vehicle markets [20][17]. Growth Drivers - The demand for domestic scientific instruments has surged due to U.S. export controls and renewed tariff conflicts, leading to a significant increase in the need for domestic alternatives [9][10]. - Companies such as Chuan Instruments and Juguang Technology have made significant strides in the localization of mass spectrometry and chromatography instruments, reflecting a positive trend in technological innovation and market potential [9][10]. Challenges and Outlook - Despite the positive trends, companies like He Xin Instruments face challenges with declining revenues in core segments, raising concerns about sustainability despite recent stock price increases [12][11]. - The article concludes that the competition in the instrument industry is far from over, with the potential for significant growth through technological innovation and strategic adjustments [20].

Core Viewpoint - Jiangxi Province has initiated a public bidding process for the "Monitoring Capacity Construction (Phase II Project)" with a total budget of 1.08 billion yuan, aiming to procure 478 sets of various high-end analytical instruments, emphasizing the encouragement of domestic instrument procurement [2][3]. Summary by Sections Project Overview - The Jiangxi Provincial Ecological Environment Monitoring Center has launched the public bidding for the "Monitoring Capacity Construction (Phase II Project)" with a total budget of 1.08 billion yuan, planning to purchase 478 sets of various instruments [3][4]. Procurement Details - The procurement list includes multiple high-end instruments such as liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS), with specific requirements for domestic products, reflecting recognition of domestic technology and promoting local industry development [3][4]. Budget and Instrument Breakdown - The total budget for the project is 1.08 billion yuan, with detailed allocations for different packages: - New pollutant investigation monitoring capacity procurement: 834 million yuan for 15 sets [4] - Laboratory instrument updates: 727 million yuan for 1 set [4] - Drinking water source water quality monitoring capacity procurement: 881 million yuan for 19 sets [4] - Ecological environment on-site monitoring capacity procurement: 431 million yuan for 9 sets [4] - Laboratory function optimization procurement: 400 million yuan for 2 sets [4]. Specific Instrument Procurement - The procurement includes various instruments with specific budget allocations: - For Package A of new pollutant investigation: 834 million yuan for instruments like pressurized fluid extraction systems and LC-MS [5]. - For Package B: 807 million yuan for similar instruments [7]. - For Package C: 734 million yuan for high-resolution mass spectrometry [9]. - For Package D: 791 million yuan for additional LC-MS and extraction systems [11]. Contract Execution Timeline - The delivery timeline for domestic products is set at 60 days post-contract signing, while imported products have a timeline of 80 days [6][8].

Core Viewpoint - The article discusses the recent institutional research conducted on Steel Research Nake, highlighting its national testing base layout, service coverage capabilities, advantages in instrument business, growth drivers for testing and instrument sectors, and shareholder return policies [1][2]. Company Overview - Steel Research Nake is an innovative enterprise specializing in the research, development, and application of metal material testing technology. The company offers services including testing services, analytical instruments, standard materials, capability verification services, corrosion protection engineering, and other extended testing services. Its applications span various industries such as steel, metallurgy, aerospace, nuclear power, and food [3]. Financial Performance - As of 2024, the company achieved a revenue of 1,097.67 million yuan, a year-on-year increase of 15.60%. The net profit attributable to shareholders was 145.02 million yuan, up 15.37% year-on-year. Basic earnings per share were 0.3861 yuan, reflecting a 15.25% increase. By March 31, 2025, the revenue reached 219.06 million yuan, a 7.18% increase year-on-year, with a net profit of 16.08 million yuan, up 33.28% year-on-year, and basic earnings per share of 0.0428 yuan, a 32.10% increase [4]. Testing Base Layout - The company has strategically laid out national testing bases in cities such as Beijing, Kunshan, Chengdu, Shenyang, Qingdao, Xi'an, Zhuozhou, and Zhuzhou, effectively meeting customer needs based on their distribution characteristics [5]. Instrument Business Advantages - The company’s instrument products cover over 60 types across eight categories, including atomic emission spectroscopy, mass spectrometry, gas analysis, and mechanical performance testing. Notable products include the spark direct reading spectrometer, which has won national awards, and the company leads in sales within the industry [6]. Market Opportunities - The domestic instrument industry is experiencing significant growth potential, driven by complex international conditions that accelerate the domestic replacement process, providing more opportunities for local scientific instrument manufacturers [7]. Future Development Directions - The company aims to enhance its testing and instrument businesses by exploring additional testing needs beyond metal materials, improving management efficiency, and increasing automation. In the instrument sector, the focus will be on improving product quality and expanding market share in high-end scientific instruments [8]. Growth Drivers - The growth of the company is supported by the rapid development of new materials in China and increasing demand for testing in key sectors such as aerospace and nuclear power. The scientific instrument sector is also benefiting from favorable policies, leading to accelerated domestic production [9]. Business Focus Areas - The company is focusing its testing business on high-demand areas such as aerospace and nuclear power, while also expanding into other material testing sectors, maintaining its competitive edge in metal material testing [10]. Shareholder Return Policy - The company emphasizes market value management and shareholder returns, maintaining a cash dividend policy where the proportion of cash dividends to net profit has consistently exceeded 30% in recent years [11].

Core Viewpoint - Hitachi High-Technologies Group has officially launched its tungsten filament scanning electron microscope produced at its Suzhou factory, which matches the performance of imported products, and will continue to deepen its presence in the Chinese market by providing higher quality services [2][4]. Group 1 - Hitachi High-Technologies Group is a subsidiary of the Fortune Global 500 company Hitachi Ltd, known for its cutting-edge technology and reliable quality in precision manufacturing [4]. - Since entering the Chinese market in 1964, Hitachi High-Tech has actively served Chinese customers for 60 years, adhering to the strategic concept of "In China, For China" [4]. - The company has established three major factories in China, located in Suzhou, Dalian, and Shanghai, responsible for the R&D and manufacturing of scientific instruments and medical diagnostic products, making it a crucial part of Hitachi's global manufacturing system [4]. Group 2 - In response to the changing demands of the Chinese market, Hitachi High-Tech's localization process has made significant progress with the launch of the tungsten filament scanning electron microscope in 2025, marking a further step in its localization strategy within the field of electron optics [6]. - The domestically produced tungsten filament scanning electron microscope is recognized for its excellent imaging, high automation, and stable quality, and will match the performance of imported models [6]. - Leveraging the established sales and after-sales service network of Hitachi Scientific Instruments (Beijing) Co., Ltd., the company aims to provide better services to Chinese users, committing to grow together with them [6].

Core Viewpoint - Shenzhen BGI Intelligent Manufacturing Co., Ltd. has won a bid for the Shanghai CDC biobank project, amounting to 50.5 million RMB, aimed at providing advanced storage and management systems to support disease prevention and precision medicine development [1][2]. Group 1: Project Details - The project is officially titled "Biobank Storage and Management Facilities for Shanghai CDC" and was announced on May 29, 2025 [2][3]. - The bid amount for the project is 50.5 million RMB, which translates to approximately 7.1 million USD [2][3]. - BGI Intelligent Manufacturing's subsidiary, BGI Intelligent Storage, will provide solutions including the "MGICLab-LT620Prem" for the project [3]. Group 2: Company Overview - BGI Intelligent Manufacturing (stock code: 688114) is a global leader in life science core tools, focusing on the development of gene sequencers, laboratory automation, and multi-omics technologies [4]. - The company's biobank product line emphasizes intelligence, automation, and high security, catering to storage needs across a full temperature range from -196°C to 4°C [4]. - BGI's solutions are widely applied in research, healthcare, agriculture, and genetic resource conservation [4].